Indonesia vs Kazakhstan: Cases started on MDR-TB treatment
Indonesia
9,421
in 2024
Kazakhstan
4,641
in 2024
Indonesia rank
4th
Kazakhstan rank
7th
Cases started on MDR-TB treatment over time
- Indonesia
- Kazakhstan
How they compare
Indonesia currently reports 9,421 against 4,641 in Kazakhstan, a difference of 4,780.
That makes Indonesia's figure about 2.0 times Kazakhstan's.
The two have swapped places 1 time across 16 shared years of data; in 2009 it was Kazakhstan ahead.
Indonesia ranks 4th and Kazakhstan ranks 7th of 193 countries.
Across the 3 decades both report, Indonesia averaged higher in 1 and Kazakhstan in 2.
Head to head by decade
| Decade | Indonesia | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20 | 3,209 | 3,189 | Kazakhstan |
| 2010s | 1,927 | 6,228 | 4,301 | Kazakhstan |
| 2020s | 7,542 | 4,665 | 2,877 | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Indonesia or Kazakhstan?
- Indonesia, at 9,421 against 4,641 in Kazakhstan as of 2024.
- What is the difference in cases started on mdr-tb treatment between Indonesia and Kazakhstan?
- 4,780, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Kazakhstan?
- 16 years are reported by both, from 2009 to 2024.
- How do Indonesia and Kazakhstan rank globally for cases started on mdr-tb treatment?
- Indonesia ranks 4th and Kazakhstan ranks 7th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.